The global ENT devices market size is expected to reach USD 23.1
billion by 2022, according to a new report by Grand View Research, Inc.,
expanding at a CAGR of 5.0% during the forecast period. Rising geriatric
population and increasing prevalence of ENT related disorders are the primary
factors stoking the growth of the market.
According to WHO, 33.0% of geriatric population and 15.0% of adult
population worldwide suffer from hearing disordersBesides this, in 2015, 13,560
new cases were registered according to the National Cancer Institute.
Increasing cases of hearing disorders are estimated to increase the usage of
hearing devices.
Technological advancements and user-friendly ENT devices are
further projected to drive the industry. For instance, use of thermoplastic
material for development of nasal splints is gaining demand. Developing
economies such as South Africa, Brazil, China, and India are anticipated to
provide significant opportunities for the growth of the market due to unmet
healthcare needs coupled with presence of target population.
Hearing aids were the largest segment in 2016. Rising target
population, high accessibility, and significantly high usage are the key
factors contributing to the growth of the market. The hearing implants segment
is likely to witness fast growth during the forecast period due to introduction
of technologically advanced devices and soaring rate of patient compliance
overcoming social stigma towards use of such devices.
Further key findings from the report suggest:
- Cochlear
implant is one of the largest segments of the hearing implants market.
Growing customization in cochlear implants is the major factor responsible
for its higher usage
- North
America dominated the market in terms of revenue in 2016, due to presence
of well-established healthcare infrastructure, favorable government
initiatives, and high awareness levels of practitioners and patients
- Asia
Pacific is projected to be the fastest growing region over the forecast
period and it’s due to favorable government policies, rising levels of
healthcare expenditure, improving healthcare infrastructure, and clinical
advancements in product development
- Major
players are introducing novel devices to increase their market share. For
instance, HiQ+ series of bipolar endoscopes by Olympus Medical Systems and
Soundbridge by MED-EL.
Grand View Research has segmented the global ENT devices market on
the basis of product, and region:
ENT Devices Product Outlook (Revenue, USD Million, 2012 - 2022)
- Diagnostic
Ear, Nose, And Throat (ENT) Devices
- Rigid
Endoscopes
- Rhinoscopes
- Laryngoscopes
- Otological
Endoscopes
- Flexible
Endoscopes
- Robot
Assisted Endoscope
- Hearing
Screening Device
- Surgical
Ear, Nose, And Throat (ENT) Devices
- Radiofrequency
Handpieces
- Powered
Surgical Instrument
- Otological
Drill Burrs
- ENT
Hand Instruments
- Tympanostomy
Tubes
- Sinus
Dilation Devices
- Nasal
Packing Devices
- Hearing
Aids Ear, Nose, And Throat (ENT) Devices
- Behind-the-Ear
(BTE) aids
- In-the-Ear
aids
- Receiver-in-the-Ear
(RITE)
- Canal
hearing aids ITC, CIC and IIC
- Hearing
Implants Ear, Nose, And Throat (ENT) Devices
- Auditory
Brainstem Implants
- Cochlear
Implants
- Middle
Ear Implants
- Bone
Anchored Hearing System
- Nasal
Splints Ear, Nose, And Throat (ENT) Devices
- Internal
Nasal Splints
- External
Nasal Splints
ENT Devices Regional Outlook (Revenue, USD Million, 2012 -
2022)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East & Africa
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
No comments:
Post a Comment